IE
IPSC icon

Israel Englander’s Century Therapeutics IPSC Stock Holding History

Israel Englander’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
4,194,981
-472,082
-10% -$1.08M ﹤0.01% 2253
2026
Q1 		$10.5M Buy
4,667,063
+4,056,676
+665% +$8.53M ﹤0.01% 2120
2025
Q4 		$607K Sell
610,387
-133,394
-18% -$81.4K ﹤0.01% 4819
2025
Q3 		$370K Sell
743,781
-68,432
-8% -$36.9K ﹤0.01% 5243
2025
Q2 		$454K Buy
+812,213
New +$436K ﹤0.01% 4964
2025
Q1 		– Sell
-1,607,174
Closed -$1.62M – 6120
2024
Q4 		$1.62M Buy
1,607,174
+1,466,415
+1,042% +$2M ﹤0.01% 3799
2024
Q3 		$241K Sell
140,759
-237,874
-63% -$466K ﹤0.01% 5331
2024
Q2 		$966K Buy
378,633
+21,232
+6% +$67.1K ﹤0.01% 4133
2024
Q1 		$1.49M Buy
357,401
+218,441
+157% +$925K ﹤0.01% 3978
2023
Q4 		$461K Buy
+138,960
New +$253K ﹤0.01% 4690
2023
Q3 		– Sell
-56,009
Closed -$177K – 6330
2023
Q2 		$177K Sell
56,009
-19,545
-26% -$63K ﹤0.01% 5165
2023
Q1 		$262K Sell
75,554
-153,304
-67% -$673K ﹤0.01% 5002
2022
Q4 		$1.17M Buy
228,858
+161,345
+239% +$1.52M ﹤0.01% 4005
2022
Q3 		$668K Buy
67,513
+6,946
+11% +$73.2K ﹤0.01% 4703
2022
Q2 		$509K Buy
+60,567
New +$594K ﹤0.01% 4937
2021
Q4 		– Sell
-69,024
Closed -$1.74M – 7091
2021
Q3 		$1.74M Sell
69,024
-112,140
-62% -$3.04M ﹤0.01% 4082
2021
Q2 		$5.32M Buy
+181,164
New +$4.6M ﹤0.01% 2677

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Israel Englander's IPSC Position: Q2 2026 in Review

Israel Englander reduced its Century Therapeutics (IPSC) stake by 10% in Q2 2026, selling an estimated $1.08M and leaving 4,194,981 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Israel Englander first reported a position in IPSC in Q2 2021 and has held it in 17 quarters since. The position peaked at $10.5M in Q1 2026. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Israel Englander held 4,194,981 shares of Century Therapeutics worth $10.3M as of Q2 2026.
  • Israel Englander sold 472,082 Century Therapeutics shares in Q2 2026, an estimated $1.08M.
  • Century Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2253 holding.
  • Israel Englander first reported a position in Century Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Israel Englander's Century Therapeutics position peaked at $10.5M in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.